Seizure remission and relapse in adults with intractable epilepsy: a cohort study.

Epilepsia
Hyunmi ChoiW A Hauser

Abstract

To investigate the cumulative probabilities of >or=12 month seizure remission and seizure relapse following remission, and to test the associations of clinical characteristics with these two study end points in a prevalence cohort of intractable adult epilepsy patients during medical management. A retrospective cohort study of intractable epilepsy patients seen in 2001 at a single center was conducted. Kaplan-Meier analysis was used to estimate the cumulative probabilities of seizure remission and subsequent seizure relapse. Cox proportional hazards models were used to estimate the association (1) between clinical factors and >or=12 month seizure remission and (2) between clinical factors and seizure relapse following remission. One hundred eighty-seven subjects met the eligibility criteria for intractable epilepsy. The estimate of probability of remission was about 4% per year. Seizure remission was temporary for some individuals, as 5 out of 20 subjects with remission ultimately relapsed. No clinical factors predicted the likelihood of achieving >or=12 month seizure remission or subsequent seizure relapse. Some people with intractable epilepsy achieve >or=12 month seizure remission during medical treatment. Remission, however...Continue Reading

References

Oct 1, 1990·Electroencephalography and Clinical Neurophysiology·J Gotman
Nov 1, 1990·Annals of Neurology·P R Huttenlocher, R J Hapke
Jul 1, 1996·Neurology·D E BlumR S Fisher
Feb 5, 2000·The New England Journal of Medicine·P Kwan, M J Brodie
Apr 6, 2001·Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society·W O TatumJ Liporace
Aug 4, 2001·The New England Journal of Medicine·S WiebeUNKNOWN Effectiveness and Efficiency of Surgery for Temporal Lobe Epilepsy Study Group
Nov 10, 2001·Brain & Development·R Riikonen
Jan 13, 2006·Brain : a Journal of Neurology·Matti Sillanpää, Dieter Schmidt
May 11, 2006·Annals of Neurology·Anne T BergSusan Smith
Nov 23, 2006·Epilepsia·Kyoung HeoByung In Lee
Jan 27, 2007·Annals of Neurology·Anna L Luciano, Simon D Shorvon
Sep 21, 2007·Annals of Neurology·Brian C CallaghanJacqueline A French

❮ Previous
Next ❯

Citations

May 4, 2010·Current Neurology and Neuroscience Reports·Kanjana UnnwongseNancy Foldvary-Schaefer
Apr 5, 2011·Current Neurology and Neuroscience Reports·Heidi Munger Clary, Hyunmi Choi
Apr 6, 2013·European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society·J Helen CrossLieven Lagae
Sep 12, 2012·Nature Reviews. Neurology·Samuel Wiebe, Nathalie Jette
Sep 9, 2011·The New England Journal of Medicine·Patrick KwanMartin J Brodie
Jan 29, 2011·Epilepsia·Brian CallaghanJacqueline French
May 11, 2012·Neurology·M J BrodieP Kwan
Feb 11, 2012·Current Opinion in Neurology·Samuel Wiebe, Nathalie Jetté
Dec 5, 2013·Epilepsia·Dong Wook KimUNKNOWN Korean Epilepsy Society
Jan 10, 2012·Epilepsy & Behavior : E&B·David E FriedmanRonnie S Tobias
Nov 15, 2011·Neurología : publicación oficial de la Sociedad Española de Neurología·J C Sánchez-ÁlvarezUNKNOWN Grupo de Estudio de Epilepsia de la Sociedad Española de Neurología
Mar 23, 2011·Epilepsy & Behavior : E&B·Michael R JohnsonMartin J Brodie
Feb 21, 2014·Journal of Neurology, Neurosurgery, and Psychiatry·Brian CallaghanJacqueline French
Jan 29, 2011·Epilepsy & Behavior : E&B·Frank G Gilliam, Brenda Albertson
May 18, 2016·Current Neurology and Neuroscience Reports·Robert A McGovernGuy M McKhann
Jun 28, 2016·Seizure : the Journal of the British Epilepsy Association·G C HotanM B Westover
Jan 26, 2017·Journal of Neurology·Mark Manford
Mar 29, 2018·Epilepsia Open·Yicong Lin, Yuping Wang
Oct 16, 2013·Nature Reviews. Neurology·Patricia Dugan, Orrin Devinsky
Mar 29, 2018·Epilepsia Open·Hai ChenDaniel Friedman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.